Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oxley Cannabis Group was a private investment and holding company focused on the global medical cannabis sector. The company's primary asset was Holigen Holdings, which developed one of the largest outdoor cannabis cultivation facilities in the world located in Aljustrel, Portugal, along with a GMP-certified indoor facility in Sintra. In 2019, The Flowr Corporation acquired Oxley's interest in Holigen to expand its footprint into the European and Australian medical markets. The group played a pivotal role in establishing large-scale, pharmaceutical-grade cannabis production infrastructure designed to meet international regulatory standards. Following the acquisition, the group's operations were integrated into Flowr's global strategy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oxley Cannabis Group.